Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease

(2018) Casey M. Rebholz et al.   KIDNEY INTERNATIONAL

The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens

(2017) Laura Díaz-Alvarez et al.   MEDIATORS OF INFLAMMATION

Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?

(2016) Valérie Desmedt et al.   AMERICAN JOURNAL OF NEPHROLOGY

Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease

(2016) Junko Nio-Kobayashi   ANATOMICAL SCIENCE INTERNATIONAL

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities

(2016) Giovanni Musso et al.   DIABETES CARE

Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure

(2016) Benjamin French et al.   JOURNAL OF CARDIAC FAILURE

Galectin-3 in autoimmunity and autoimmune diseases

(2015) Felipe L de Oliveira et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance

(2015) Ernesto Martínez-Martínez et al.   HYPERTENSION

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

(2015) C. Drechsler et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

(2014) Josef Coresh et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor?

(2014) H. Yilmaz et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

(2013) Shweta R. Motiwala et al.   EUROPEAN JOURNAL OF HEART FAILURE

Elevated Galectin-3 Precedes the Development of CKD

(2013) C. M. O'Seaghdha et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice

(2013) Jingbo Pang et al.   PLoS One

Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

(2012) Lili Yu et al.   Circulation-Heart Failure

Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3

(2012) Zexu Dang et al.   TRANSPLANTATION

Serum Galectin-3 Is Elevated in Obesity and Negatively Correlates with Glycosylated Hemoglobin in Type 2 Diabetes

(2010) Johanna Weigert et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Dynamics of galectin-3 in the nucleus and cytoplasm

(2009) Kevin C. Haudek et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis

(2008) Neil C. Henderson et al.   AMERICAN JOURNAL OF PATHOLOGY